Patient Communication and Utilization of JAK Inhibitors in Atopic Dermatitis

Opinion
Video

An expert in the treatment of atopic dermatitis shares her perspectives on patient communication and treatment optimization practices.

Video content above is prompted by the following questions:

  • How do you educate and counsel patients who want to consider or are currently using a JAK inhibitor?
    • How do you discuss treatment targets and manage patient expectations?
  • What suggestions do you have for patients and healthcare professionals to optimize treatment of AD with JAK inhibitors?
Recent Videos
Wendy Wright, DNP, an expert on fibromyalgia
A panel of 3 experts on atopic dermatitis
A panel of 3 experts on atopic dermatitis
1 KOL is featured in this series.
A panel of 3 experts on atopic dermatitis
A panel of 3 experts on atopic dermatitis
1 KOL is featured in this series.
Dennis M. Marcus, MD , an expert on neovascular AMD
A panel of 3 experts on atopic dermatitis
A panel of 3 experts on atopic dermatitis
© 2024 MJH Life Sciences

All rights reserved.